Please assess the completion status of the following clinical trial:

Trial Title: Effects of Subtenon-injected Autologous Platelet-rich Plasma on Visual Functions in Eyes With Retinitis Pigmentosa

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~18 years of age or older;~* Diagnosis of any phenotypic variation of RP, confirmed by clinical history, fundus appearance, VF, and electroretinogram;~* Experience of various degrees of VF loss;~* BCVA from light perception of up to 110 letters (equal to 1.6 decimal values) in early treatment of diabetic retinopathy study (ETDRS) chart testing (Topcon CC-100 XP, Japan); \& Mean deviation (MD) values from-33.0 to-5.0 dB with Humphrey or Octopus 900 visual field analysis (threshold 30-2, Sita Standard, Stimulus 3-white);~* Intraocular pressure (IOP) \<22 mmHg.~Exclusion Criteria:~* The presence of cataracts or other media opacity that might affect the VF, MP, or mfERG recordings;~  * The presence of glaucoma, which causes visual field and optic disc changes;~ * The presence of any systemic disorder(e.g.,diabetes,neurological disease, or uncontrolled systemic hypertension) that may affect visual functions;~ * The habit of smoking.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- Before application (Type: ACTIVE_COMPARATOR): Forty-nine eyes belonging to 37 patients before injection aPRP.
- After application (Type: NO_INTERVENTION): Forty-nine eyes belonging to 37 patients after injection aPRP.
- Sham application (Type: SHAM_COMPARATOR): 11 patients before - after aPPP injection

Based on this trial design, predict the completion outcome and termination type (if applicable).